Jazz Pharmaceuticals (JAZZ) PT Raised to $225 at Barclays

October 26, 2020 5:14 AM EDT
Get Alerts JAZZ Hot Sheet
Price: $245.85 -1.25%

Rating Summary:
    33 Buy, 5 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Barclays analyst Balaji Prasad raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $225.00 (from $205.00) while maintaining a Overweight rating.

You May Also Be Interested In





Related Categories

Analyst PT Change